The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...
A new memoir, "Unshrunk," offers a scathing critique of the psychiatric drug industry, and forges a new path to healing.
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught ...
The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments ...
1d
Inquirer.net on MSNFDA adds 17 products to list of VAT-free drugsThe Food and Drug Administration (FDA) has added 17 drug products to its list of essential medication exempted from the 12 ...
1d
Verywell Health on MSN7 Medications for Dementia and Alzhiemer's DiseaseMedication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.
Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.
The anti-amyloid therapy gantenerumab lowered the chances for developing Alzheimer’s-related dementia in people at high risk for the disease, according to a small study conducted by the Knight Family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results